Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duke University
With
Ventricle Health
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥18 years of age
Acute decompensated HF as a primary cause of hospitalization. Hospitalizations for acute decompensated HF will be determined by local clinician-investigators but should include findings of acute HF (i.e., symptoms, signs, and/or laboratory/imaging abnormalities) and treatments aimed at acute HF (e.g., intravenous diuretics, vasodilators, or inotropes). Participants with a new diagnosis of HF may be enrolled. The enrollment will be monitored to ensure no more than 2/3 of the total cohort has new-onset HF.
Fluent in written and spoken English
You may not be if
Optimized or nearly optimized on evidence-based medical therapies for HF as determined by local investigator
Current pregnancy
Chronic use of intravenous inotropic medications including milrinone, dobutamine, or dopamine
eGFR of \<20 mL/min/1.73m2 ongoing chronic dialysis at screening. The eGFR should be estimated using the 2021 Chronic Kidney Disease Epidemiology Collaboration (2021 CKD-EPI) creatinine equation.
History of prior heart transplant or currently listed for heart transplant
Current left ventricular assist device or planned left ventricular assist device in the next 6 months
Currently receiving hospice care
Chronically resides in an assisted living or skilled nursing facility where medications are managed by facility personnel
Terminal illness other than HF with a life expectancy of \<1 year as determined by the enrolling clinician-investigator
